NeoGenomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
NeoGenomics, Inc. (NEO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $6.42 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-24.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2023-02-24
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $6.42, a 65.98% decline from fiscal 2021.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $18.87, a 112.50% increase from fiscal 2020.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $8.88, a 53.90% increase from fiscal 2019.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $5.77, a 106.07% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2022-12-31 | $6.42 10-K · filed 2023-02-24 |
| 2021-12-31 | $18.87 10-K · filed 2022-02-25 |
| 2020-12-31 | $8.88 10-K · filed 2021-02-25 |
| 2019-12-31 | $5.77 10-K · filed 2020-02-28 |
| 2018-12-31 | $2.80 10-K · filed 2019-02-26 |
| 2017-12-31 | $2.26 10-K · filed 2018-03-13 |
| 2016-12-31 | $2.23 10-K · filed 2017-03-14 |
| 2015-12-31 | $2.55 10-K · filed 2016-04-18 |
| 2014-12-31 | $1.50 10-K · filed 2015-03-03 |
| 2013-12-31 | $1.20 10-K · filed 2014-02-24 |
| 2012-12-31 | $943000.00 10-K · filed 2013-02-21 |
| 2011-12-31 | $267000.00 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |